IP Library Granted Patent US 8,354,128
Granted Patent B2
US 8,354,128 · App. 12/095,679 · Granted Jan 15, 2013

Blackberry leaf extract as an active ingredient against skin irritations and inflammations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,354,128
App. No.
12/095,679
Granted
Jan 15, 2013
Kind
B2
Abstract

The present invention concerns the field of plant extracts and their uses, in particular for cosmetic, oral hygiene and pharmaceutical purposes. In particular the invention concerns blackberry leaf extracts and preparations and medicaments containing them, as well as their use to inhibit irritating and inflammatory skin conditions.

Claims (20)

1. A process for inhibiting and/or relieving a skin irritation and/or a skin inflammation in a subject in need thereof, comprising applying a preparation to an area of the subject's skin to be treated, wherein said preparation comprises a leaf extract of Rubus fruticosus (blackberry) in a sufficient concentration to inhibit and/or relieve the skin irritation and/or skin inflammation and/or in a sufficient concentration to reduce the release of an interleukin, wherein the blackberry leaf extract is obtained by a process comprising:

a) adding an extractant comprising ethanol and water to blackberry leaves, wherein the ratio of ethanol to water is 2:8 to 8:2: and

b) extracting the blackberry leaves with the extractant for up to 72 hours, and wherein the preparation does not comprise berries, branches or roots of Rubus fruticosus.

2. A process for reducing the release of an interleukin in a subject in need thereof, comprising applying a preparation to an area of the subject's skin to be treated, wherein said preparation comprises a leaf extract of Rubus fruticosus (blackberry) in a sufficient concentration to reduce the release of the interleukin and/or to relieve a skin irritation and/or a skin inflammation, wherein the blackberry leaf extract is obtained by or obtainable by a process comprising:

a) adding an extractant comprising ethanol and water to blackberry leaves, wherein the ratio of ethanol to water is 2:8 to 8:2: and

b) extracting the blackberry leaves with the extractant for up to 72 hours, and wherein the preparation does not comprise berries, branches or roots of Rubus fruticosus.

3. A process for inhibiting and/or relieving a skin irritation and/or a skin inflammation in a subject in need thereof, comprising applying a medicament to an area of skin to be treated, wherein said medicament comprises a leaf extract of Rubus fruticosus (blackberry) in a sufficient concentration to inhibit and/or relieve the skin irritation and/or skin inflammation, wherein the blackberry leaf extract is obtained by a process comprising:

a) adding an extractant comprising ethanol and water to blackberry leaves, wherein the ratio of ethanol to water is 2:8 to 8:2: and

b) extracting the blackberry leaves with the extractant for up to 72 hours, and wherein the preparation does not comprise berries, branches or roots of Rubus fruticosus.

4. A process for reducing the release of an interleukin in a subject in need thereof, comprising applying a medicament to an area of the subject's skin wherein said medicament comprises a leaf extract of Rubus fruticosus (blackberry) in a sufficient concentration to reduce the release of the interleukin and/or to inhibit and/or relieve a skin irritation and/or a skin inflammation, wherein the blackberry leaf extract is obtained by a process comprising:

a) adding an extractant comprising ethanol and water to blackberry leaves, wherein the ratio of ethanol to water is 2:8 to 8:2: and

b) extracting the blackberry leaves with the extractant for up to 72 hours, and wherein the preparation does not comprise berries, branches or roots of Rubus fruticosus.

5. The process according to claim 1 , wherein the leaf extract is obtained by a process further comprising:

c) adding a solid carrier, which is acceptable for pharmaceutical, oral hygiene and/or cosmetic purposes, to the extract; and

d) drying the extract with the added solid carrier until a residual content of extractant, comprising at most 5 wt. % based on the total weight of the extract obtained in step d), is obtained.

6. The process according to claim 2 , wherein the leaf extract is obtained by a process further comprising:

c) adding a solid carrier, which is acceptable for pharmaceutical, oral hygiene and/or cosmetic purposes, to the extract; and

d) drying the extract with the added solid carrier until a residual content of extractant, comprising at most 5 wt. % based on the total weight of the extract obtained in step d), is obtained.

7. The process according to claim 1 , wherein the extractant contains a proportion of at least 15 wt. % of water.

8. The process according to claim 2 , wherein the extractant contains a proportion of at least 15 wt. % of water.

Assignments (2)
MERGER Recorded Apr 22, 2011
From: SYMRISE GMBH & CO. KG
To: SYMRISE AG
Reel/Frame 026171/0582 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: VIELHABER, GABRIELE; HERRMANN, MARTINA; MEYER, IMKE; JOPPE, HOLGER
To: SYMRISE GMBH & CO. KG
Reel/Frame 024507/0638 →